Currently, numerous HDT approaches are available for TB therapy, including enhancing autophagy, promoting phagosome maturation, inhibiting mTOR, inhibiting inflammation or necrotic cell death, and cytokine therapy [39]. The gene discussed is MTOR; the disease is tuberculosis.